SCHEMBL7107499

SCHEMBL7107499

CCCC=C(C(=O)CBr)C(=O)OCCCC

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.42
ALDH1A1 P00352 2/20 0.40
TSHR P16473 5/20 0.40
HPGD P15428 1/20 0.40
FAAH O00519 5/20 0.39
HCAR2 Q8TDS4 3/20 0.38
NAAA Q02083 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
EP300 Q09472 1/20 0.36
MAPT P10636 1/20 0.33
RAB9A P51151 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HSD17B10 Q99714 1/20 0.33
ESR1 P03372 1/20 0.33
TP53 P04637 1/20 0.33
CYP3A4 P08684 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7107496 1.00 ATM (0.42) ATMALDH1A1TSHRHPGDFAAH
SCHEMBL7104841 0.95 FAAH (0.44) ATMALDH1A1TSHRFAAHHCAR2
SCHEMBL7104844 0.95 FAAH (0.44) ATMALDH1A1TSHRFAAHHCAR2
SCHEMBL7100073 0.94 ATM (0.42) ATMALDH1A1TSHRHPGDFAAH
SCHEMBL7100076 0.94 ATM (0.42) ATMALDH1A1TSHRHPGDFAAH
SCHEMBL7104207 0.92 EP300 (0.46) ATMALDH1A1TSHRHPGDFAAH
SCHEMBL7104211 0.92 EP300 (0.46) ATMALDH1A1TSHRHPGDFAAH
SCHEMBL7107112 0.90 HCAR2 (0.34) ALDH1A1FAAHHCAR2EP300NPSR1
SCHEMBL7107108 0.90 HCAR2 (0.34) ALDH1A1FAAHHCAR2EP300NPSR1
SCHEMBL7100789 0.89 FAAH (0.48) TSHRFAAHHCAR2NAAAEP300

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1000939-B1 Producing z-isomer of hydrogen bromide salt of 2-aminothiazole derivative SUMITOMO CHEMICAL CO (JP) 2003-09-17 EP disclosed
US-6403572-B1 REACTING ACID SALT OF A 2-AMINOTHIAZOLE COMPOUND WITH INORGANIC ACID SUMITOMO CHEMICAL CO., LTD. (JP) 2002-06-11 US disclosed
US-20020058818-A1 Producing Z-isomer of hydrogen bromide salt of 2-aminothiazole derivative SUMITOMO CHEMICAL CO., LTD. 2002-05-16 US disclosed
US-6340763-B1 SALT FORMATION AND CRYSTALLIZATION, REACTION OF HALOGENATED COMPOUND AND THIOUREA COMPOUND SUMITOMO CHEMICAL CO., LTD. (JP) 2002-01-22 US disclosed
EP-1000939-A1 Producing z-isomer of hydrogen bromide salt of 2-aminothiazole derivative SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2000-05-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020058818-A1 Producing Z-isomer of hydrogen bromide salt of 2-aminothiazole derivative ZYX, H1-0, HAO2 ATM 3560/4885ALDH1A1 2333/4885TSHR 698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.